The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis

The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis

<p>Abstract</p> <p>Background</p> <p>We conducted the present study to investigate the therapeutic effects of a combination treatment of alfacalcidol (ALF) and risedronate (RIS) on the bone mechanical properties of bone and calcium (Ca) metabolism using an ovariectomize...

Full description

Bibliographic Details
Main Authors:	Ito Masako, Umakoshi Yukichi, Nakano Takayoshi, Miyabe Sayaka, Shiraishi Ayako, Mihara Masahiko
Format:	Article
Language:	English
Published:	BMC 2009-06-01
Series:	BMC Musculoskeletal Disorders
Online Access:	http://www.biomedcentral.com/1471-2474/10/66

Similar Items

Disturbance of osteonal bone remodeling and high tensile stresses on the lateral cortex in atypical femoral fracture after long-term treatment with Risedronate and Alfacalcidol for osteoporosis
by: Fumitaka Hirano, et al.
Published: (2021-06-01)

Retraction: Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats
Published: (2019-01-01)

Once-monthly risedronate for postmenopausal osteoporosis
by: Kristina Casadei, et al.
Published: (2009-02-01)

Alfacalcidol in prevention and treatment of osteoporosis of endocrine genesis in children and adolescents
by: V. V. Smirnov, et al.
Published: (2021-06-01)

Efficiency of Ibandronate in Monotherapy and in Combination with Alfacalcidol in Women with Postmenopausal Osteoporosis
by: S.I. Ismailov, et al.
Published: (2016-09-01)

The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model
by: Amy L. Inselman, et al.
Published: (2024-04-01)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
by: Raja Bobba, et al.
Published: (2007-10-01)

Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats.
by: Tingjun Ye, et al.
Published: (2017-01-01)

Sustained anti-osteoporotic action of risedronate compared to anti-RANKL antibody following discontinuation in ovariectomized mice
by: Toshinobu Omiya, et al.
Published: (2020-12-01)

EFFECT OF ALENDRONATE COMBINED WITH ALFACALCIDOL ON THE BIOLOGICAL STABILITY OF HIP JOINT ENDOPROSTHESIS IN PATIENTS WITH SYSTEMIC OSTEOPOROSIS
by: S S Rodionova, et al.
Published: (2013-12-01)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
by: Tahir Masud, et al.
Published: (2009-11-01)

Evaluation of twelve vibration regimes applied to improve spine properties in ovariectomized rats
by: Marina Komrakova, et al.
Published: (2017-12-01)

Effects of risedronate, alendronate, and minodronate alone or in combination with eldecalcitol on bone mineral density, quality, and strength in ovariectomized rats
by: Tetsuo Yano, et al.
Published: (2021-06-01)

Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
by: Cooper, C, et al.
Published: (2001)

The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment
by: Mizue Tanaka, et al.
Published: (2014-01-01)

Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation
by: Boyanov M, et al.
Published: (2012-04-01)

Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis
by: Ban Hadi Hameed
Published: (2018-10-01)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
by: María J Moro-Álvarez, et al.
Published: (2008-06-01)

Effect of alfacalcidol on bone regeneration in senile rats
by: F.V. Klymovytskyy, et al.
Published: (2022-12-01)

Early bioprosthetic valve calcification with alfacalcidol supplementation
by: Takano Tamaki, et al.
Published: (2013-01-01)

Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.
by: Seeman, A, et al.
Published: (2000)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
by: Paula Rackoff
Published: (2009-05-01)

Efficacy of risedronate in a post-menopausal woman affected by osteoporosis and inflammatory bowel disease
by: Stefano Palomba, et al.
Published: (2010-06-01)

Concordane of OSTA and lumbar spine BMD by DXA in identifying risk of osteoporosis
by: Cai YunHua, et al.
Published: (2006-11-01)

Intermittent Oral Versus Intravenous Alfacalcidol in Dialysis Patients
by: Mitwalli Ahmed, et al.
Published: (2000-01-01)

The treatment of secondary hyperparathyroidism in haemodialysis patients' refractory to alfacalcidol
by: L V Egshatyan, et al.
Published: (2012-06-01)

THE EFFECTIVENESS OF ZINC AND RISEDRONATE ON BONE TURNOVER IN RAT MODEL OF OSTEOPOROSIS ASSESSED WITH THE EXPRESSION OF β-CROSSLAPS
by: Adam Fajar, et al.
Published: (2019-12-01)

Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate: In Vivo Evaluation and Bioavailability Enhancement
by: Zoya Saifi, et al.
Published: (2023-09-01)

Effects of soybean isoflavone aglycone on osteoporosis in ovariectomized rats
by: Lu-lu Li, et al.
Published: (2023-06-01)

EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN
by: S S Rodionova, et al.
Published: (2016-12-01)

A 3-year postmarketing study on the safety and effectiveness of once-monthly risedronate in Japanese patients with osteoporosis
by: Satoshi Soen, et al.
Published: (2020-12-01)

Peroxygenase-Catalyzed Selective Synthesis of Calcitriol Starting from Alfacalcidol
by: Yuanying Li, et al.
Published: (2022-05-01)

Denosumab alleviates intervertebral disc degeneration adjacent to lumbar fusion by inhibiting endplate osteochondral remodeling and vertebral osteoporosis in ovariectomized rats
by: Qi Sun, et al.
Published: (2021-05-01)

Dark-field X-ray imaging for the assessment of osteoporosis in human lumbar spine specimens
by: Florian T. Gassert, et al.
Published: (2023-07-01)

Prediction of osteoporosis and osteopenia by routine computed tomography of the lumbar spine in different regions of interest
by: Guangyue Yang, et al.
Published: (2022-10-01)

Absorption and bioavailability of nano-size reduced calcium citrate fortified milk powder in ovariectomized and ovariectomized-osteoporosis rats
by: Erfanian, Arezoo, et al.
Published: (2015)

Calcium and Strontium Coordination Polymers as Controlled Delivery Systems of the Anti-Osteoporosis Drug Risedronate and the Augmenting Effect of Solubilizers
by: Maria Vassaki, et al.
Published: (2021-12-01)

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
by: M Stevenson, et al.
Published: (2005-06-01)

Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis
by: Calabria S, et al.
Published: (2016-04-01)

Correction to: Denosumab alleviates intervertebral disc degeneration adjacent to lumbar fusion by inhibiting endplate osteochondral remodeling and vertebral osteoporosis in ovariectomized rats
by: Qi Sun, et al.
Published: (2021-09-01)